• Tomentodione M Reverses MDR by Targeting P-gp via p38 MAPK I

  2026-07-27

  The reference study uncovers how tomentodione M, a meroterpenoid, restores sensitivity to chemotherapeutics like Docetaxel in multidrug resistant (MDR) cancer cells by downregulating P-glycoprotein through p38 MAPK pathway inhibition. This mechanistic insight offers researchers a new angle to overcome MDR in cancer chemotherapy research, especially where P-gp overexpression limits drug efficacy.

• Recombinant Mouse Sonic Hedgehog: Evidence, Protocol, and Pi

  2026-07-26

  Recombinant Mouse Sonic Hedgehog (SHH) protein is a validated morphogen essential for studies of the hedgehog signaling pathway and embryonic patterning. This article reviews its mechanism, evidence base, and practical research integration. Key benchmarks and limitations are clarified for developmental biology applications.

• Reframing GABAB Antagonism: Astrocyte-Driven Synaptic Modula

  2026-07-25

  This thought-leadership article explores how CGP 55845 hydrochloride, a potent GABAB receptor antagonist, empowers translational neuroscience by enabling unprecedented dissection of astrocyte-mediated synaptic regulation. We bridge mechanistic insights from recent dentate gyrus research with actionable guidance for experimental design, highlighting the strategic value of integrating glial biology into in vitro neurotransmission assays and outlining the implications for cognitive disorder modeling.

• Topotecan (SKF104864): Advanced Antitumor Strategies in Pedi

  2026-07-24

  Explore the unique properties of Topotecan (SKF104864), a potent topoisomerase I inhibitor, in pediatric cancer research. This in-depth article uncovers advanced applications, novel assay insights, and protocol guidance for maximizing antitumor outcomes.

• Fenipentol for Pancreatic and Hepatic Research: Applied Work

  2026-07-24

  Fenipentol (1-Phenyl-1-pentanol) stands out for its dual role: modulating bile and pancreatic secretions and enabling mechanistic investigations of anti-fibrotic pathways in hepatic models. Its quantified effects and robust solubility profile make it an indispensable tool for gastrointestinal and metabolism research workflows.

• Angiotensin III (human, mouse): Mechanistic Insights and Tra

  2026-07-23

  Explore the multifaceted role of Angiotensin III in RAAS signaling, its AT2 receptor specificity, and its translational impact on both cardiovascular and viral pathogenesis research. This article provides a deep mechanistic analysis, bridging peptide biochemistry with emerging assay strategies.

• LMO2–LDB1 Complex Drives AML Progression via Transcriptional

  2026-07-23

  This study uncovers the oncogenic role of the LMO2/LDB1 transcriptional complex in acute myeloid leukemia (AML). Using genetic and molecular approaches, the authors demonstrate that LDB1 is essential for AML cell proliferation and survival, highlighting a new molecular target for leukemia intervention.

• Astrocytic GAT-3 Modulates Synaptic Transmission and Memory

  2026-07-22

  This study reveals how astrocytic GAT-3 regulates synaptic transmission and contextual memory formation in the dentate gyrus. By integrating electrophysiology, optogenetics, and behavioral assays, the research dissects the astrocyte-mediated mechanisms of GABAergic signaling, offering new insights for cognitive neuroscience and potential therapeutic strategies.

• Broad-Spectrum Bivalent mRNA Vaccine Counters SARS-CoV-2 Var

  2026-07-22

  This study presents RQ3025, a novel bivalent mRNA vaccine engineered to induce broad and potent neutralizing antibody responses against multiple SARS-CoV-2 variants in animal models. The findings demonstrate improved immune protection and safety compared to monovalent vaccines, providing a promising foundation for next-generation COVID-19 immunization strategies.

• Indole-3-pyruvic Acid: Protocols for Plant and Immuno-Oncolo

  2026-07-21

  Indole-3-pyruvic acid (IPA) bridges plant hormone research and immune modulation, offering precision tools for both auxin biosynthesis studies and mammalian disease models. This guide details advanced IPA workflows, key innovations from microbiome–cancer studies, and troubleshooting insights tailored to maximize experimental reliability.

• Strategic Use of CGP 55845 Hydrochloride in Synaptic Circuit

  2026-07-21

  This article delivers a thought-leadership perspective on leveraging CGP 55845 hydrochloride for probing GABAB-mediated synaptic transmission, with mechanistic insight drawn from astrocytic GAT-3 research and actionable strategic guidance for translational neuroscientists. By connecting molecular pharmacology with cutting-edge glia-neuron circuit findings, it equips researchers to design robust, future-facing in vitro studies in the context of cognitive health.

• Tranexamic Acid in Fibrinolysis Research: Protocols and Inno

  2026-07-20

  Tranexamic Acid is redefining antifibrinolytic research by enabling fast, robust clot stabilization and infection control in advanced wound care models. This article translates bench-side breakthroughs into actionable workflows and troubleshooting insights for maximizing the reproducibility and impact of your fibrinolysis assays.

• Itraconazole: Advanced Workflows for Candida Biofilm & Drug

  2026-07-20

  Itraconazole stands out as a triazole antifungal agent, enabling both mechanistic studies of Candida drug resistance and translational antifungal research. This article details advanced, evidence-driven workflows and practical troubleshooting to maximize APExBIO’s Itraconazole in biofilm, drug interaction, and angiogenesis inhibition assays.

• Resazurin Cell Viability Assay Kit: Precision for Proliferat

  2026-07-19

  The Resazurin Cell Viability Assay Kit from APExBIO delivers unmatched sensitivity and non-toxicity for quantifying live cell populations, streamlining workflows across diverse biological applications. Its dual-mode detection and ready-to-use format set a new standard for high-throughput, reproducible viability analysis.

• Flavopiridol (L868275): Precision Cell Cycle Arrest in Cance

  2026-07-18

  Flavopiridol (L868275) from APExBIO sets the benchmark in selective cyclin-dependent kinase inhibition, empowering researchers to induce robust cell cycle arrest and apoptosis across cancer and stem cell models. This article delivers actionable workflows, troubleshooting strategies, and protocol guidance, drawing on recent mechanistic insights and real-world data to maximize experimental reproducibility and translational impact.

8535 records 7/569 page Previous Next First page 上5页 678910 下5页 Last page